Figure 1.
(a) Viability of HCT-116 and (b) SW620 human colorectal cancer cell lines treated with Agarikon Plus (AP) or Agarikon.1 (AG.1) (1:10–1:100,000), as well as on (c) human lung fibroblasts (WI-38) (1:2–1:20,000). Cell viability was determined by 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The data are expressed as mean ± SD of cell viability in comparison with control (at 100%) from three independently performed experiments. * Significantly different (* p < 0.05; *** p < 0.001, nonparametric Kruskal–Wallis test) in comparison with control group.
